COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,646 Articles (22,913 medRxiv, 8,733 bioRxiv)

Most recent first Previous |  Page 363: Articles 3621-3630  | Next

Forecasting regional-level COVID-19 hospitalisation in England as an ordinal variable using the machine learning method
Wang, H., Riley, S., Kwok, K. O., Li, R.
10.1101/2023.10.17.23297138 — Posted: 2023-10-17
Single cell transcriptomics-level Cytokine Activity Prediction and Estimation (SCAPE)
Javaid, A., Frost, H. R.
10.1101/2023.10.17.562739 — Posted: 2023-10-17
Cross-sector collaboration reduces SARS-CoV-2 risk in deer
Cook, J. D., Rosenblatt, E., DiRenzo, G. V., Campbell Grant, E. H., Mosher, B., Arce, F., Christensen, S., Ghai, R., Runge, M.
10.1101/2023.10.13.562192 — Posted: 2023-10-17
Did long COVID increase road deaths in the U.S.?
Robertson, L. S.
10.1101/2023.10.11.23296868 — Posted: 2023-10-16
Trends in Nationally Notifiable Infectious Diseases in Humans and Animals During the COVID-19 Pandemic in South Korea
Chang, T., Cho, S.-i., Yoo, D.-s., Min, K.-D.
10.1101/2023.10.16.23297064 — Posted: 2023-10-16
Covid-19 Related Generalized Anxiety Disorder Among Health Care Workers In A Hospital In The Greater Accra Region
Ohakpougwu, C. E., Bebobru, W. M.
10.1101/2023.10.16.23297097 — Posted: 2023-10-16
Analysis the molecular similarity of least common amino acid sites in ACE2 receptor to predict the potential susceptible species for SARS-CoV-2
YeZhi, H., Fan, X., Villalan, A. K., Zhang, S., Joka, F. R., Wu, X., Wang, H., Wang, X.
10.1101/2023.10.13.562198 — Posted: 2023-10-16
V-pipe 3.0: a sustainable pipeline for within-sample viral genetic diversity estimation
Fuhrmann, L., Jablonski, K. P., Topolsky, I., Batavia, A. A., Borgsmueller, N., Icer Baykal, P., Carrara, M., Chen, C., Dondi, A., Dragan, M., Dreifuss, D., John, A., Langer, B., Okoniewski, M., du Plessis, L., Schmitt, U., Singer, F., Stadler, T., Beerenwinkel, N.
10.1101/2023.10.16.562462 — Posted: 2023-10-16
Evaluation of Stroke Risk Following COVID-19 mRNA Bivalent Vaccines Among U.S. Adults Aged >=65 Years
Lu, Y., Matuska, K., Nadimpalli, G., Ma, Y., Duma, N., Zhang, H., Chiang, Y., Lyu, H., Chillarige, Y., Forshee, R. A., Anderson, S. A.
10.1101/2023.10.10.23296624 — Posted: 2023-10-15
Safety of Monovalent BNT162b2 (Pfizer-BioNTech), mRNA-1273 (Moderna), and NVX-CoV2373 (Novavax) COVID-19 Vaccines in US Children Aged 6 months to 17 years
Lloyd, P. C., Hu, M., Shoaibi, A., Feng, Y., Wong, H. L., Smith, E. R., Amend, K. L., Kline, A., Beachler, D. C., Gruber, J. F., Mitra, M., Seeger, J. D., Harris, C., Secora, A., Obidi, J., Wang, J., Song, J., McMahill-Walraven, C. N., Reich, C., McEvoy, R., Do, R., Chillarige, Y., Clifford, R., Cooper, D. D., Forshee, R. A., Anderson, S. A.
10.1101/2023.10.13.23296903 — Posted: 2023-10-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).